Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in a Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine인도에서 여행하는 41명의 학생 그룹에서 SARS-CoV-2 Delta 변종 감염의 두 개별 클러스터: 엄격한 테스트 및 검역의 필요성에 대한 예시Article Published on 2022-05-312022-09-11 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] affecting Antigen B.1.617.2 Belgium Cluster communicable communicable disease Communicable disease control community transmission Contact tracing contribute country COVID-19 decrease Delta delta variant disease disease control eight Extensive Follow-up France Genome sequencing genomic group highlight illustration India Infection infections measure New outbreak Paris Prevent quarantine quarantine measures remained repeated reported SARS-CoV-2 SARS-CoV-2 variants Separate Sequencing severe symptom severe symptoms student Surveillance tested Testing vaccination Vaccination Status Viral load [DOI] 10.3390/v14061198 PMC 바로가기 [Article Type] Article
Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, IndiaCOVID-19 재감염 및 그 예측인자(CORES)의 위험: 인도 벨로르에서 지역사회 기반 종단 코호트 연구를 위한 프로토콜Article Published on 2022-05-242022-09-11 Journal: BMJ Open [Category] COVID19(2023년), SARS, 치료기술, [키워드] analysed antibody Antibody responses approved attack rate B cell memory baseline blood sample Blood samples collected college Community community setting COVID-19 defined detect elicited Ethics evaluated Evidence evidence of expected Factor General population group Health policy healthy immune response immune responses immunology incidence India Infection institutional review board IRB Kinetics Longevity longitudinal cohort study natural infection positive Post-infection predictor presence of antibody Primary infection protocol public health Re-infection recruit registration number registry responses reverse transcription-PCR risk risk factor Risk factors RT-PCR Saliva saliva samples SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 infections SARS-CoV-2 spike protein seronegative seropositive Seropositivity Seroprevalence seroprevalence survey Spike protein T cell T cell memory tested understanding vaccination Vaccination Status Weekly [DOI] 10.1136/bmjopen-2021-059869 PMC 바로가기 [Article Type] Article
Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemicCOVID-19 대유행 전과 동안, 동반이환 및 예방접종 상태에 따른 개인의 사회적 접촉의 시간 경향Article Published on 2022-05-232022-09-11 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95%CI analyses Analysis booster dose booster doses Canada Christma Comorbidities Comorbidity Complication conducted Contact COVID-19 COVID-19 complications COVID-19 pandemic COVID-19 vaccination cross-sectional described distance Efficacy explained first dose First wave Generalized linear model greater Immune escape individual Infectious diseases Intervention masking medical condition medication MONITOR outcome pandemic participant performed physical contact Poisson distribution Public public health Quebec, Canada questionnaire random recruited repeated risk of COVID-19 robust second wave significant difference significantly social contact Social contacts the mean the vaccine time used data vaccination Vaccination Status Vaccine vaccine efficacy variant [DOI] 10.1186/s12916-022-02398-x PMC 바로가기 [Article Type] Article
The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence코스타리카에서 심각한 COVID-19를 예방하기 위한 Pfizer-BioNTech 및 Oxford-AstraZeneca 백신의 효과: 입원 유병률에 대한 전국 생태학적 연구Observational Study Published on 2022-05-202022-09-11 Journal: JMIR Public Health and Surveillance [Category] COVID19(2023년), SARS, 변종, 임상, 치료기술, [키워드] 95% CI Administered Analysis AstraZeneca Complete condition Costa Rica Costa Rican Coverage COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines declined delta variant detect determine dominant dose dose-dependent effective Effectiveness Epidemiology estimate evaluated first dose hospital Hospitalization hospitalizations Hospitalized information Intervention monitoring Observational observational study Older Older age outcome Oxford-AstraZeneca Pfizer-BioNTech Policy Prevalence Prevent prevention real-world second dose severity single dose Single-dose study period Surveillance vaccination Vaccination Status Vaccine Vaccines variant virus [DOI] 10.2196/35054 PMC 바로가기 [Article Type] Observational Study
The roles of inactivated vaccines in older patients with infection of Delta variant in Nanjing, China중국 난징에서 Delta 변이형 감염 고령 환자에서 불활성화 백신의 역할Article Published on 2022-05-182022-09-11 Journal: Aging (Albany NY) [Category] COVID19(2023년), SARS, 변종, [키워드] Acute kidney injury acute respiratory distress acute respiratory distress syndrome ARDS BBIBP-CorV cardiac injury China Clinical severity co-morbidities CoronaVac coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccines Delta delta variant demographic data dose dose of vaccination effective enrolled evaluated group Hospital stay IMPROVE inactivated Inactivated vaccine Inactivated Vaccines incidence Infection Injury Laboratory parameters less MODS morbidities multiple organ dysfunction multiple organ dysfunction syndrome Nanjing Older older patient older patients organ dysfunction organ dysfunction syndrome organ dysfunction. pandemic Patient respiratory distress Septic shock syndrome three group three groups vaccination Vaccination Status were recorded with infection [DOI] 10.18632/aging.204085 PMC 바로가기 [Article Type] Article
Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study기계 학습 기반 병원 내 COVID-19 질병 결과 예측기(CODOP) 개발 및 평가: 다대륙 후향적 연구Article Published on 2022-05-172022-09-11 Journal: eLife [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] allocation AUROC breakthrough infections calibrated Clinical outcome clinical parameter clinical utility clinically Cohort cohort of patient Computational biology country COVID-19 COVID-19 disease COVID-19 patient deaths development disperse effective heterogeneous hospital Hospital admission hospital resources Hospitalization hospitalizations hospitalized COVID-19 patients Human In-hospital Latin Latin America machine-learning maintain Medicine New offer outcome pandemic patient cohort patient cohorts prediction Predictive Retrospective study risk stratification SARS-CoV-2 variants sensitivity Spain specificity Systems biology tested Triage USA vaccination vaccination rate Vaccination Status variant virus waning immunity [DOI] 10.7554/eLife.75985 PMC 바로가기 [Article Type] Article
An excitation wavelength-optimized, stable SERS biosensing nanoplatform for analyzing adenoviral and AstraZeneca COVID-19 vaccination efficacy status using tear samples of vaccinated individuals백신 접종자의 눈물 샘플을 사용하여 아데노바이러스 및 AstraZeneca COVID-19 예방 접종 효능 상태를 분석하기 위한 여기 파장 최적화된 안정적인 SERS 바이오 센싱 나노 플랫폼Article Published on 2022-05-152022-09-11 Journal: Biosensors & bioelectronics [Category] COVID19(2023년), SARS, 치료기술, [키워드] Adenovirus antibody AstraZeneca AZD1222 ChAdOx1 COVID-19 vaccination Efficacy Epidemic Epidemic keratoconjunctivitis fluids Hypothesis identify Immunoglobulin Immunoglobulin G Keratoconjunctivitis lAbel Label-free SERS biosensing platform limit of detection marker Near- and far-field properties Non-invasive Oxford-AstraZeneca Oxford-AstraZeneca vaccine Patient platform product receive reproducibility robust robustness scattering stability Stability and robustness Standard deviation Tear Tear fluids. tears the vaccine vaccinated individual vaccinated individuals vaccination Vaccination Status Vaccine [DOI] 10.1016/j.bios.2022.114079 PMC 바로가기 [Article Type] Article
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated personsSARS-CoV-2 Omicron 변이의 급속한 출현은 예방 접종을 받은 사람에서 Delta보다 감염 이점과 관련이 있습니다.Article Published on 2022-05-132022-09-11 Journal: Med (New York, N.Y.) [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] analyzed CDC center collected Connecticut Control COVID-19 COVID-19 vaccines Delta delta variant determine disease control displacement dominant dose doses doubling driven by Epidemiology Factor Generalized genomic Genomic surveillance higher odd higher odds Infection infections Linear model nasal swab odds of infection omicron Omicron variants PCR test positive prevention proportion Rapid reduction in SARS-CoV-2 spike gene Spread supported Surveillance vaccination Vaccination Status Vaccine vaccine dose vaccine doses Vaccine-induced immunity variant virus were infected were used [DOI] 10.1016/j.medj.2022.03.010 PMC 바로가기 [Article Type] Article
Continued effectiveness of COVID-19 vaccination among urban healthcare workers during delta variant predominance델타 변이가 우세한 동안 도시 의료 종사자들 사이에서 COVID-19 예방 접종의 지속적인 효과Article Published on 2022-05-122022-09-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI accounted acquired immunity adjusted Analysis Community contributed contributing to covariate covariates COVID COVID-19 COVID-19 diagnosis COVID-19 incidence COVID-19 vaccination COVID-19 vaccine delta variant demographics Effectiveness Epidemiologic surveillance Evidence evidence of HCW HCWs healthcare worker Healthcare workers Immunity immunization incidence incidence rate Infection information information bias Massachusett Massachusetts naturally acquired immunity provide Re-infection Real-world evidence resulting risk robustness SARS-CoV-2 study period subject vaccination Vaccination Status Vaccine variant [DOI] 10.1186/s12879-022-07434-y PMC 바로가기 [Article Type] Article
Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in SwedenArticle Published on 2022-05-092023-07-08 Journal: Vaccine [Category] COVID19(2023년), [키워드] country of birth COVID19 Epidemiology healthcare worker Hesitancy Register SARS-CoV-2 uptake Vaccination Status Vaccine vaccine coverage [DOI] 10.1016/j.vaccine.2022.04.014 PMC 바로가기